
CAS 1153949-38-2
:3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile
Description:
3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile is a complex organic compound characterized by its unique structural features, including a cyclopentyl group and a pyrazole moiety. The presence of a dioxaborolane ring contributes to its potential reactivity and applications in organic synthesis, particularly in the context of boron chemistry. The nitrile functional group indicates the presence of a carbon triple-bonded to nitrogen, which can influence the compound's polarity and reactivity. This compound may exhibit interesting biological or pharmacological properties due to its diverse functional groups, making it a candidate for research in medicinal chemistry. Additionally, the steric hindrance introduced by the tetramethyl groups may affect its interaction with biological targets or catalysts. Overall, the compound's characteristics suggest potential utility in various chemical applications, including drug development and materials science, although specific properties such as solubility, melting point, and stability would require empirical investigation.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
1H-Pyrazole-1-propanenitrile, β-cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS:Formula:C17H26BN3O2Purity:97%Color and Shape:SolidMolecular weight:315.21823-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile
CAS:<p>3-Cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile</p>Purity:97%β-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile-d8
CAS:Controlled Product<p>Applications β-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile-d8 is an intermediate in the synthesis of Ruxolitinib (R701995), a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.<br>References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);<br></p>Formula:C17H18D8BN3O2Color and Shape:NeatMolecular weight:323.273-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile
CAS:Formula:C17H26BN3O2Purity:97%Molecular weight:315.22β-Cyclopentyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-propanenitrile
CAS:Controlled ProductFormula:C17H26BN3O2Color and Shape:NeatMolecular weight:315.22




